Liraglutide/insulin degludec
Liraglutide/insulin degludec is a combination medication used in the treatment of type 2 diabetes. It combines liraglutide, a GLP-1 receptor agonist, with insulin degludec, a long-acting insulin analog, to improve blood sugar control in adults with type 2 diabetes. This combination allows for the benefits of both medications, potentially reducing the number of injections needed and simplifying diabetes management.
Medical uses[edit | edit source]
Liraglutide/insulin degludec is indicated for the treatment of adults with type 2 diabetes mellitus when both liraglutide and insulin degludec are appropriate treatments. It is used alongside diet and exercise to improve glycemic control. Liraglutide works by increasing insulin secretion in response to high blood sugar levels, while insulin degludec provides a steady release of insulin to lower baseline blood sugar levels.
Administration[edit | edit source]
The medication is administered via subcutaneous injection. Patients should be instructed on proper injection techniques to minimize side effects and ensure effectiveness. The dosing of liraglutide/insulin degludec is individualized based on the patient's current treatment regimen, effectiveness, and tolerability.
Side effects[edit | edit source]
Common side effects include nausea, diarrhea, and headache. More serious side effects may include pancreatitis, hypoglycemia, and allergic reactions. Patients should be monitored for signs of pancreatitis and hypoglycemia and adjust their dosage as necessary.
Pharmacology[edit | edit source]
Liraglutide mimics the action of GLP-1, enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon secretion, and slowing gastric emptying. Insulin degludec is designed to form a depot of insulin crystals in the subcutaneous tissue, from which small amounts of insulin are continuously released, providing a long duration of action.
Interactions[edit | edit source]
Liraglutide/insulin degludec may interact with other medications, including sulfonylureas and glucocorticoids, which can increase the risk of hypoglycemia. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.
See also[edit | edit source]
 | This category is for stub articles relating to Endocrine, nutritional and metabolic disease related. You can help by expanding them. To add an article to this category, use {{Endocrine, nutritional and metabolic disease stubs}} instead of {{stub}}. |
This Endocrine, nutritional and metabolic disease related article is a stub.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
